Related Experiment Video
Updated: Aug 30, 2025

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
Novel Antimicrobial Peptide "Octoprohibitin" against Multidrug Resistant Acinetobacter baumannii
E H T Thulshan Jayathilaka1, Dinusha C Rajapaksha1, Chamilani Nikapitiya1
1College of Veterinary Medicine and Research Institute of Veterinary Medicine, Chungnam National University, Yuseong-gu, Daejeon 34134, Korea.
Abstract:
Octoprohibitin is a synthetic antimicrobial peptide (AMP), derived from the prohibitin-2 gene of Octopus minor. It showed substantial activity against multidrug resistant (MDR) Acinetobacter baumannii with a minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of 200 and 400 µg/mL, respectively. Time-kill kinetics and bacterial viability assays confirmed the concentration-dependent antibacterial activity of octoprohibitin against A. baumannii. The morphology and ultrastructure of A. baumannii were altered by treatment with octoprohibitin at the MIC and MBC levels. Furthermore, propidium iodide-fluorescein diacetate (PI-FDA) staining and 2',7'-dichlorodihydrofluorescein diacetate (H2DCFDA) staining of octoprohibitin-treated A. baumannii revealed membrane permeability alterations and reactive oxygen species (ROS) generation, respectively. Agarose gel retardation results confirmed the DNA-binding ability of octoprohibitin to the genomic DNA of A. baumannii. Furthermore, octoprohibitin showed concentration-dependent inhibition of biofilm formation and eradication. The minimum biofilm inhibition concentration (MBIC) and minimum biofilm eradication concentration (MBEC) of octoprohibitin were 1000 and 1460 µg/mL, respectively. Octoprohibitin produced no significant cytotoxicity up to 800 µg/mL, and no hemolysis was observed up to 400 µg/mL. Furthermore, in vivo analysis in an A. baumannii-infected zebrafish model confirmed the effective bactericidal activity of octoprohibitin with higher cumulative survival percent (46.6%) and fewer pathological signs. Histological analysis showed reduced alterations in the gut, kidney, and gill tissues in the octoprohibitin-treated group compared with those in the phosphate-buffered saline (PBS)-treated group. In conclusion, our results suggest that octoprohibitin is a potential antibacterial and antibiofilm agent against MDR A. baumannii.
Insights
Octoprohibitin, a synthetic antimicrobial peptide, effectively combats multidrug-resistant Acinetobacter baumannii by disrupting bacterial membranes and DNA. This peptide also inhibits biofilm formation and shows promise in treating infections in zebrafish models with low toxicity.
Area of Science:
- Microbiology
- Peptide Science
- Drug Discovery
Background:
- Multidrug-resistant (MDR) Acinetobacter baumannii poses a significant threat due to limited treatment options.
- Antimicrobial peptides (AMPs) represent a promising alternative to conventional antibiotics.
Purpose of the Study:
- To evaluate the antibacterial and antibiofilm activity of octoprohibitin, a synthetic AMP derived from Octopus minor.
- To investigate the mechanism of action of octoprohibitin against MDR A. baumannii.
- To assess the in vivo efficacy and safety of octoprohibitin.
Main Methods:
- Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) assays.
- Time-kill kinetics, bacterial viability, and morphological/ultrastructural analyses.
- Propidium iodide-fluorescein diacetate (PI-FDA) and H2DCFDA staining for membrane permeability and ROS generation.
- Agarose gel electrophoresis for DNA-binding.
- Biofilm inhibition and eradication assays (MBIC, MBEC).
- Cytotoxicity and hemolysis assays.
- In vivo efficacy study in an A. baumannii-infected zebrafish model.
Main Results:
- Octoprohibitin demonstrated potent activity against MDR A. baumannii (MIC: 200 µg/mL, MBC: 400 µg/mL).
- It induced membrane permeability alterations, reactive oxygen species (ROS) generation, and DNA binding.
- Effective inhibition and eradication of A. baumannii biofilms were observed (MBIC: 1000 µg/mL, MBEC: 1460 µg/mL).
- Octoprohibitin exhibited low cytotoxicity and no hemolysis at effective concentrations.
- In vivo studies showed significant survival improvement (46.6%) and reduced pathological signs in infected zebrafish.
Conclusions:
- Octoprohibitin is a potent antibacterial agent against MDR A. baumannii.
- Its mechanism involves membrane disruption, ROS generation, and DNA binding.
- Octoprohibitin also possesses significant antibiofilm properties.
- The peptide demonstrates a favorable safety profile and in vivo efficacy, suggesting its potential as a therapeutic agent.
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Gene Regulation in Microbial Communities: Quorum Sensing
Antimicrobial Effectiveness

